For biotech companies the past two years have been challenging. Biotech investments have not reached the record levels of ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend on to treat autoimmune diseases or cancers. The Food and Drug ...

This board strengthens Serpin Pharma’s ability to advance innovative immune‑modulating therapeutics and expand our ...

Biotech stocks are in focus as analysts track upcoming clinical data and regulatory decisions in autoimmune and rare disease ...

Nvidia announced AI partnerships with two biotech firms to transform the way lifesaving drugs are discovered and manufactured.

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

FAR Biotech, a computational drug discovery company using proprietary quantum modeling and deep learning AI to tackle high impact diseases with significant unmet medical need, today announced that it ...

But deciding if it's a good buy takes a little more looking.